1
|
Elias Chitio JJ, Baltazar CS, Langa JP, Baloi LD, Mboane RBJ, Manuel JA, Assane S, Omar A, Manso M, Capitine I, Van Rensburg C, Luiz N, Mogasale V, Marks F, Park SE, Beck NS. Pre-emptive oral cholera vaccine (OCV) mass vaccination campaign in Cuamba District, Niassa Province, Mozambique: feasibility, vaccination coverage and delivery costs using CholTool. BMJ Open 2022; 12:e053585. [PMID: 36547726 PMCID: PMC9454037 DOI: 10.1136/bmjopen-2021-053585] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
INTRODUCTION Mozambique suffers from regular floods along its principal river basins and periodic cyclones that resulted in several cholera epidemics during the last decades. Cholera outbreaks in the recent 5 years affected particularly the northern provinces of the country including Nampula and Niassa provinces. A pre-emptive oral cholera vaccine (OCV) mass vaccination campaign was conducted in Cuamba District, Niassa Province, and the feasibility, costs, and vaccination coverage assessed. METHODS WHO prequalified OCV (Euvichol-Plus), a killed whole-cell bivalent vaccine containing Vibrio cholerae O1 (classical and El Tor) and O139, was administered in two doses with a 15-day interval during 7-31 August 2018, targeting around 180 000 people aged above 1 year in Cuamba District. Microplanning, community sensitisation, and training of local public health professionals and field enumerators were conducted. Feasibility and costs of vaccination were assessed using CholTool. Vaccination coverage and barriers were assessed through community surveys. RESULTS The administrative coverage of the first and second rounds of the campaign were 98.9% (194 581) and 98.8% (194 325), respectively, based on the available population data that estimated total 196 652 inhabitants in the target area. The vaccination coverage survey exhibited 75.9% (±2.2%) and 68.5% (±3.3%) coverage for the first and second rounds, respectively. Overall, 60.4% (±3.4%) of the target population received full two doses of OCV. Barriers to vaccination included incompatibility between working hours and campaign time. No severe adverse events were notified. The total financial cost per dose delivered was US$0.60 without vaccine cost and US$1.98 including vaccine costs. CONCLUSION The pre-emptive OCV mass vaccination campaign in remote setting in Mozambique was feasible with reasonable full-dose vaccination coverage to confer sufficient herd immunity for at least the next 3 to 5 years. The delivery cost estimate indicates that the OCV campaign is affordable as it is comparable with Gavi's operational support for vaccination campaigns.
Collapse
Affiliation(s)
- Jucunú J Elias Chitio
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
| | - Cynthia S Baltazar
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
| | - José Paulo Langa
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
| | - Liliana Dengo Baloi
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
| | | | | | - Sadate Assane
- Provincial Directorate of Health, Lichinga City, Mozambique
| | - Alide Omar
- District Health Directorate, Cuamba District, Mozambique
| | - Mariana Manso
- District Health Directorate, Cuamba District, Mozambique
| | - Igor Capitine
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
| | - Craig Van Rensburg
- Policy and Economic Research Department, International Vaccine Institute, Seoul, Republic of Korea
| | - Naira Luiz
- National Department for Surveillance and Surveys in Health, National Institute of Health, Maputo, Mozambique
- Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea
| | - Vittal Mogasale
- Policy and Economic Research Department, International Vaccine Institute, Seoul, Republic of Korea
| | - Florian Marks
- Epidemology, Public Health, Impact (EPIC) Unit, International Vaccine Institute, Seoul, Republic of Korea
| | - Se Eun Park
- Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea
- Yonsei University Graduate School of Public Health, Seoul, Republic of Korea
| | - Namseon S Beck
- Clinical, Assessment, Regulatory, Evaluation (CARE) Unit, International Vaccine Institute, Seoul, Republic of Korea
- Medair Headquarters, Ecublens, VD, Switzerland
| |
Collapse
|
2
|
Bodenham RF, Mtui-Malamsha N, Gatei W, Woldetsadik MA, Cassell CH, Salyer SJ, Halliday JE, Nonga HE, Swai ES, Makungu S, Mwakapeje E, Bernard J, Bebay C, Makonnen YJ, Fasina FO. Multisectoral cost analysis of a human and livestock anthrax outbreak in Songwe Region, Tanzania (December 2018-January 2019), using a novel Outbreak Costing Tool. One Health 2021; 13:100259. [PMID: 34013015 PMCID: PMC8113743 DOI: 10.1016/j.onehlt.2021.100259] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 04/27/2021] [Accepted: 04/27/2021] [Indexed: 02/08/2023] Open
Abstract
OBJECTIVES We applied a novel Outbreak Costing Tool (OCT), developed by the US Centers for Disease Control and Prevention (CDC), to estimate the costs of investigating and responding to an anthrax outbreak in Tanzania. We also evaluated the OCT's overall utility in its application to a multisectoral outbreak response. METHODS We collected data on direct costs associated with a human and animal anthrax outbreak in Songwe Region (December 2018 to January 2019) using structured questionnaires from key-informants. We performed a cost analysis by entering direct costs data into the OCT, grouped into seven cost categories: labor, office, travel and transport, communication, laboratory support, medical countermeasures, and consultancies. RESULTS The total cost for investigating and responding to this outbreak was estimated at 102,232 United States dollars (USD), with travel and transport identified as the highest cost category (62,536 USD) and communication and consultancies as the lowest, with no expenditure, for the combined human and animal health sectors. CONCLUSIONS Multisectoral investigation and response may become complex due to coordination challenges, thus allowing escalation of public health impacts. A standardized framework for collecting and analysing cost data is vital to understanding the nature of outbreaks, in anticipatory planning, in outbreak investigation and in reducing time to intervention. Pre-emptive use of the OCT will also reduce overall and specific (response period) intervention costs for the disease. Additional aggregation of the costs by government ministries, departments and tiers will improve the use of the tool to enhance sectoral budget planning for disease outbreaks in a multisectoral response.
Collapse
Affiliation(s)
- Rebecca F. Bodenham
- Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK
- Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dar es Salaam, United Republic of Tanzania
| | - Niwael Mtui-Malamsha
- Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dar es Salaam, United Republic of Tanzania
| | - Wangeci Gatei
- Division of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - Mahlet A. Woldetsadik
- Division of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - Cynthia H. Cassell
- Division of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - Stephanie J. Salyer
- Division of Global Health Protection, Center for Global Health, US Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - Jo E.B. Halliday
- Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK
| | - Hezron E. Nonga
- Directorate of Veterinary Services, Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania
| | - Emmanuel S. Swai
- Directorate of Veterinary Services, Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania
| | - Selemani Makungu
- Directorate of Veterinary Services, Ministry of Livestock and Fisheries, Dodoma, United Republic of Tanzania
| | - Elibariki Mwakapeje
- Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dar es Salaam, United Republic of Tanzania
- Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, United Republic of Tanzania
| | - Jubilate Bernard
- Ministry of Health, Community Development, Gender, Elderly and Children, Dodoma, United Republic of Tanzania
- One Health Coordination Desk, Office of the Prime Minister, Dodoma, United Republic of Tanzania
| | - Charles Bebay
- Emergency Centre for Transboundary Animal Diseases (ECTAD) Regional Office for Eastern Africa, Food and Agriculture Organization of the United Nations (FAO), Nairobi, Kenya
| | - Yilma J. Makonnen
- Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Rome, Italy
| | - Folorunso O. Fasina
- Emergency Centre for Transboundary Animal Diseases (ECTAD), Food and Agriculture Organization of the United Nations (FAO), Dar es Salaam, United Republic of Tanzania
| |
Collapse
|